New England Research & Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.5M | Buy |
29,527
+714
| +2% | +$166K | 2.92% | 6 |
|
|
2026
Q1 | $7.04M | Sell |
28,813
-420
| -1% | -$97.8K | 2.98% | 4 |
|
|
2025
Q4 | $6.05M | Sell |
29,233
-155
| -0.5% | -$30.7K | 2.65% | 5 |
|
|
2025
Q3 | $5.45M | Sell |
29,388
-375
| -1% | -$64.2K | 2.5% | 6 |
|
|
2025
Q2 | $4.55M | Buy |
29,763
+15
| +0.1% | +$2.31K | 2.16% | 9 |
|
|
2025
Q1 | $4.93M | Buy |
29,748
+2,097
| +8% | +$328K | 2.51% | 5 |
|
|
2024
Q4 | $4M | Sell |
27,651
-650
| -2% | -$101K | 2.04% | 9 |
|
|
2024
Q3 | $4.59M | Sell |
28,301
-261
| -0.9% | -$41.6K | 2.15% | 6 |
|
|
2024
Q2 | $4.17M | Sell |
28,562
-1,260
| -4% | -$187K | 2.01% | 6 |
|
|
2024
Q1 | $4.72M | Sell |
29,822
-71
| -0.2% | -$11.3K | 2.32% | 6 |
|
|
2023
Q4 | $4.68M | Sell |
29,893
-435
| -1% | -$66.7K | 2.48% | 5 |
|
|
2023
Q3 | $4.72M | Sell |
30,328
-285
| -0.9% | -$47K | 2.69% | 4 |
|
|
2023
Q2 | $5.07M | Buy |
30,613
+75
| +0.2% | +$12.1K | 2.94% | 3 |
|
|
2023
Q1 | $4.73M | Buy |
30,538
+1,393
| +5% | +$225K | 2.78% | 2 |
|
|
2022
Q4 | $5.15M | Sell |
29,145
-387
| -1% | -$66.8K | 2.96% | 1 |
|
|
2022
Q3 | $4.82M | Buy |
29,532
+2,275
| +8% | +$385K | 3.04% | 1 |
|
|
2022
Q2 | $4.84M | Buy |
27,257
+1,215
| +5% | +$216K | 2.82% | 2 |
|
|
2022
Q1 | $4.62M | Buy |
26,042
+1,190
| +5% | +$202K | 2.39% | 4 |
|
|
2021
Q4 | $4.25M | Sell |
24,852
-443
| -2% | -$72.5K | 2.06% | 7 |
|
|
2021
Q3 | $4.08M | Hold |
25,295
| – | – | 2.14% | 5 |
|
|
2021
Q2 | $4.17M | Hold |
25,295
| – | – | 2.16% | 4 |
|
|
2021
Q1 | $4.16M | Sell |
25,295
-9,702
| -28% | -$1.57M | 2.28% | 4 |
|
|
2020
Q4 | $5.51M | Sell |
34,997
-348
| -1% | -$51.4K | 3.41% | 2 |
|
|
2020
Q3 | $5.26M | Buy |
35,345
+456
| +1% | +$67.5K | 3.81% | 2 |
|
|
2020
Q2 | $4.91M | Hold |
34,889
| – | – | 3.51% | 2 |
|
|
2020
Q1 | $4.58M | Buy |
34,889
+1,775
| +5% | +$252K | 3.91% | 2 |
|
|
2019
Q4 | $4.83M | Sell |
33,114
-1,613
| -5% | -$219K | 3.24% | 2 |
|
|
2019
Q3 | $4.49M | Buy |
34,727
+1,900
| +6% | +$250K | 3.25% | 2 |
|
|
2019
Q2 | $4.57M | Sell |
32,827
-2,024
| -6% | -$280K | 3.1% | 2 |
|
|
2019
Q1 | $4.87M | Sell |
34,851
-875
| -2% | -$117K | 3.29% | 2 |
|
|
2018
Q4 | $4.61M | Sell |
35,726
-1,767
| -5% | -$246K | 3.63% | 2 |
|
|
2018
Q3 | $5.18M | Sell |
37,493
-1,625
| -4% | -$216K | 3.37% | 2 |
|
|
2018
Q2 | $4.75M | Buy |
39,118
+4,000
| +11% | +$499K | 3.14% | 2 |
|
|
2018
Q1 | $4.5M | Buy |
35,118
+3,900
| +12% | +$527K | 3.02% | 2 |
|
|
2017
Q4 | $4.36M | Sell |
31,218
-1,374
| -4% | -$191K | 3.12% | 2 |
|
|
2017
Q3 | $4.24M | Sell |
32,592
-23
| -0.1% | -$3.05K | 3.1% | 2 |
|
|
2017
Q2 | $4.32M | Sell |
32,615
-525
| -2% | -$67K | 3.19% | 2 |
|
|
2017
Q1 | $4.13M | Sell |
33,140
-703
| -2% | -$84K | 3.17% | 2 |
|
|
2016
Q4 | $3.9M | Buy |
33,843
+3,500
| +12% | +$404K | 3.06% | 2 |
|
|
2016
Q3 | $3.58M | Buy |
30,343
+5,063
| +20% | +$614K | 3% | 2 |
|
|
2016
Q2 | $3.07M | Sell |
25,280
-850
| -3% | -$96.6K | 2.64% | 3 |
|
|
2016
Q1 | $2.83M | Buy |
26,130
+900
| +4% | +$93.2K | 2.4% | 4 |
|
|
2015
Q4 | $2.59M | Sell |
25,230
-2,299
| -8% | -$231K | 2.24% | 4 |
|
|
2015
Q3 | $2.57M | Sell |
27,529
-4,529
| -14% | -$438K | 2.45% | 2 |
|
|
2015
Q2 | $3.12M | Buy |
32,058
+1,850
| +6% | +$185K | 2.56% | 2 |
|
|
2015
Q1 | $3.04M | Buy |
30,208
+1,704
| +6% | +$173K | 2.61% | 1 |
|
|
2014
Q4 | $2.98M | Sell |
28,504
-350
| -1% | -$36.9K | 2.56% | 1 |
|
|
2014
Q3 | $3.08M | Sell |
28,854
-600
| -2% | -$62.2K | 2.69% | 1 |
|
|
2014
Q2 | $3.08M | Sell |
29,454
-340
| -1% | -$34.4K | 2.76% | 1 |
|
|
2014
Q1 | $2.93M | Buy |
29,794
+437
| +1% | +$40.5K | 2.68% | 1 |
|
|
2013
Q4 | $2.69M | Buy |
+29,357
| New | +$2.71M | 2.59% | 3 |
|
Other funds holding JNJ
New England Research & Management's JNJ Position: Q2 2026 in Review
New England Research & Management increased its Johnson & Johnson (JNJ) stake by 2.5% in Q2 2026, buying an estimated $166K and bringing the position to 29,527 shares worth $7.5M. The position accounts for 2.92% of the portfolio, ranked #6.
New England Research & Management first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- New England Research & Management held 29,527 shares of Johnson & Johnson worth $7.5M as of Q2 2026.
- New England Research & Management bought 714 Johnson & Johnson shares in Q2 2026, an estimated $166K.
- Johnson & Johnson made up 2.92% of New England Research & Management's portfolio in Q2 2026, its #6 holding.
- New England Research & Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
- 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.